Ericka P. Greene, MD

Projects

Projects per year 2005 2019 2020 2044

• 3 Not started
• 9 Finished
• 15 Active

Projects per year

Search results

• Active

  Home Visits are the Answer for Homebound Patients with Amyotrophic Lateral Sclerosis

  Greene, E. P. & Thonhoff, J. R.

  5/9/24 → …

  Project: Clinical Trial

• Collaborative Remote Physical Examination: Transforming Medical and Nursing Practice

  Greene, E. P.

  9/1/23 → 8/31/26

  Project: Federal Funding Agencies

• HEALEY ALS Platform Trial - Regimen-Specific Appendix D - For pridopidine 45 mg oral capsule administered twice daily (BID) or its matching placebo.

  Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.

  6/29/21 → 7/23/25

  Project: Non Profit

• Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies

  Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.

  6/28/21 → …

  Project: Clinical Trial

• A Study of Biological Markers for the Nervous and Immune Systems and Free Radical Mediated Processes in Amyotrophic Lateral Sclerosis (ALS)

  Appel, S. H., Beers, D., Greene, E. P., Lai, E. C., Liao, B., Shroff, S., Thonhoff, J. R. & Zhao, W.

  8/13/20 → …

  Project: Clinical Trial

• HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo

  Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.

  7/24/20 → 7/23/25

  Project: Non Profit

• HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)

  Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.

  7/24/20 → 7/23/25

  Project: Non Profit

• HEALEY ALS Platform Trial - Regimen-Specific Appendix C - For CNM-Au8

  Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.

  7/24/20 → 7/23/25

  Project: Non Profit

• Massachusetts General Hospital Healey Center for ALS - Healey ALS Platform Trial

  Appel, S. H., Shroff, S., Greene, E. P. & Thonhoff, J. R.

  7/24/20 → 7/23/25

  Project: Non Profit

• Myotonic Dystrophy Compilation of Clinical Findings

  Greene, E. P., Appel, S. H., Ashizawa, T., Mathuria, N., Shroff, S. & Thonhoff, J. R.

  4/1/20 → …

  Project: Clinical Trial

• Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1: END-DM1

  Greene, E. P. & Shroff, S.

  10/8/19 → …

  Project: Clinical Trial

• Neuromuscular Observational Research (MOVR) Data Hub Protocol

  Greene, E. P., Appel, S. H., Shroff, S. & Thonhoff, J. R.

  5/17/19 → …

  Project: Clinical Trial

• A prospective, multi-center, observational study of the safety, tolerability and effectiveness of SPINRAZA in adult patients with Spinal Muscular Atrophy

  Thonhoff, J. R., Greene, E. P. & Shroff, S.

  4/26/19 → 4/25/44

  Project: Non Profit

• Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety ofOral Fingolimod in Patients with ALS

  Greene, E. P., Appel, S. H. & Lai, E. C.

  Massachusetts General Hospital

  5/13/13 → 5/12/38

  Project: Non Profit

• Multicenter Screening Trial of Safety and Efficacy of Lithium Carbonate in ALS (MDA 105838)

  Greene, E. P.

  California Pacific Medical Ctr Res Inst

  3/1/08 → 7/17/35

  Project: Non Profit

• Not started

  Genomic Translation for ALS Clinical Care

  Appel, S. H., Greene, E. P., Shroff, S. & Thonhoff, J. R.

  Project: Clinical Trial

• COMPILATIONS OF CLINICAL FINDINGS IN AMYOTROPHIC LATERAL SCLEROSIS

  Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.

  Project: Clinical Trial

• A prospective, multi-center, observational study of the safety, tolerability and effectiveness of SPINRAZA in adult patients with Spinal Muscular Atr

  Liao, B., Greene, E. P. & Shroff, S.

  Project: Clinical Trial

• Finished

  Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

  Greene, E. P.

  11/8/18 → 8/31/22

  Project: Federal Funding Agencies

• Myotonic Dystrophy Clinical Research Network (DMCRN) Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1 (DM1)

  Greene, E. P.

  6/1/18 → 11/30/22

  Project: Non Profit

• Genomic Translation for ALS Care

  Appel, S. H., Greene, E. P., Shroff, S. & Thonhoff, J. R.

  10/1/15 → 9/30/19

  Project: Non Profit

• A PILOT TRIAL OF THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF EXPANED AND INFUSED T-REGULATORY CELLS WITH IL-2 DELIVERED BY INTRAVENOUS INFUSION IN SUBJECTS WITH ALS

  Appel, S. H. & Greene, E. P.

  ALS Association

  6/1/15 → 6/1/17

  Project: Non Profit

• CD4+ CD25+ regulatory T cells as Potential Biomarkers of Pathogenesis and Response to Therapy in CIDP Patients

  Greene, E. P., Appel, S. H. & Lai, E. C.

  GBS/CIDP Foundation International

  8/22/12 → 6/30/14

  Project: Non Profit

• Clinically Meaningful Changes (CMC) Scale in dthe MDA/ALS Clinical Network

  Greene, E. P.

  Columbia University

  5/28/10 → 6/30/11

  Project: Non Profit

• Trial of High fat/High Calory Diet versus Optimal Nutrition in Amyotrophic Lateral Sclerosis

  Greene, E. P.

  Massachusetts General Hospital

  12/8/09 → 6/30/13

  Project: Non Profit

• Clinical Trial of Ceftriaxone in Subjects with ALS

  Greene, E. P.

  Massachusetts General Hospital

  12/1/05 → 12/31/14

  Project: Federal Funding Agencies

• ALS Research Group (ALSRG) Collection of Data and Biomaterial for Repoistory Banking

  Greene, E. P.

  Massachusetts General Hospital

  12/1/05 → 11/30/06

  Project: Federal Funding Agencies